What Has Been The Evolution of the Cell Line Development Market in Recent Years?
The cell line development market has seen considerable growth due to a variety of factors.
• The cell line development market has seen rapid growth in recent years. It will grow from $8.21 billion in 2024 to $9.44 billion in 2025, reflecting a compound annual growth rate (CAGR) of 14.9%.
The growth drivers include increased vaccine production, an aging population, and a higher number of clinical trials.
How Will the Cell Line Development Market?
The cell line development market is expected to maintain its strong growth trajectory in upcoming years.
• The cell line development market is projected to grow to $16.33 billion by 2029 with a CAGR of 14.7%.
The growth is driven by the increasing prevalence of cancer, chronic diseases, and government investments in healthcare. Trends include partnerships, investments, and product innovations in cell line development.
Which Factors Are Boosting Growth In The Cell Line Development Market?
The increasing prevalence of cancer is expected to drive the growth of the cell line development market. Cancer, characterized by uncontrolled cell growth, is rising due to factors such as population aging and lifestyle choices. Cell lines are used to screen potential cancer treatments. For example, in February 2024, the World Health Organization projected that cancer cases would rise by 77%, from 20 million in 2022 to 35 million by 2050. This growing cancer prevalence will drive the cell line development market.
What Key Areas Define The Segmentation Of The Global Cell Line Development Market?
The cell line development market covered in this report is segmented –
1) By Product: Reagents And Media, Equipment, Accessories And Consumables
2) By Source: Mammalian, Non-Mammalian
3) By Cell Line: Recombinant, Hybridomas, Continuous Cell Line, Primary Cell Line
4) By Application: Bioproduction, Drug Discovery, Toxicity Testing, Tissue Engineering, Research
Subsegments:
1) By Reagents And Media: Cell Culture Media, Serum-Free Media, Recombinant Protein Supplements, Growth Factors, Cytokines And Hormones, Buffers And Salts
2) By Equipment: Bioreactors And Fermenters, Incubators, Cell Counters And Analyzers, Cell Sorters, Cryopreservation Equipment, Filtration And Separation Equipment
3) By Accessories And Consumables: Culture Vessels (Flasks, Plates), Pipettes And Pipette Tips, Cell Culture Inserts, Syringes And Needles, Cryovials And Freezing Containers, Petri Dishes
Pre-Book The Cell Line Development Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Impacting The Size Of The Cell Line Development Market?
In the cell line development market, companies are creating innovative platforms to improve their competitive position. These platforms aim to streamline and optimize the cell line development process, increasing speed, efficiency, and productivity to support the development of biologic drugs. For instance, in January 2023, UK-based Abzena introduced two new platforms, AbZelect and AbZelectPro, designed to accelerate the cell line development process for biologics. These platforms enhance productivity, enabling the production of more drug substances per manufacturing run, ultimately expanding capacity, reducing costs, and speeding up the delivery of therapies.
Who Are the Key Players In The Cell Line Development Market?
Major companies operating in the cell line development market are:
• Thermo Fisher Scientific Inc.
• Novartis AG
• Danaher Corporation
• Merck KGaA
• GE Health Care
• AGC Biologics
• Corning Inc.
• Eurofins Scientific
• Lonza Pvt. Ltd.
• WuXi App tech
• Sartorius AG
• GenScript Biotech Corporation
• FUJIFILM Diosynth Biotechnologies
• Promega corporation
• KBI Biopharma Inc.
• Rentschler Biopharma SE
• Advanced Instruments LLC
• Cyagen
• Horizon Discovery Group Plc
• Probiogen AG
• PromoCell GmbH
• Premas Biotech
• Imgenex
• NAEJA RGM Pharmaceuticals Inc
What Is The Most Dominant Region In The Cell Line Development Market?
North America was the largest region in the cell line development market in 2023. The regions covered in the cell line development market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
